The Global Molecular
imaging Market, by Technology (Gamma Camera, SPECT, PET, Magnetic Resonance
Spectroscopy, Optical Imaging, and Molecular Ultrasound Imaging), by
Application (Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder,
Lung Disorder, Bone Disorder, and Others), by End User (Hospital, Diagnostic
Imaging Centers, and Others), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 3.8 billion in
2017, and is projected to exhibit a CAGR of 8.1% over the forecast period (2018
- 2026).
Defining disease processes based
on their molecular and cellular changes and advances in genomics offer promise
for earlier disease detection and molecular prevention in some cases. The field
of molecular imaging is adopting these advances and is using various
technologies to study disease states and physiology. For instance, optical
methods, such as variations of fluorescence imaging, can resolve tissue
microstructures or target specific cells using molecular probes. Mass
spectrometry offers a new modality for molecular imaging in image-guided
surgery by providing detailed information of the chemical makeup of surgical
tissue without the need for molecular probes. Molecular imaging is generally
used to improve the diagnosis and treatment of lung cancer. In breast cancer,
molecular imaging is used to minimize the removal of axillary lymph nodes by
determining which nodes are most likely to contain cancer cells. For many
gastrointestinal cancers, PET-CT, a molecular imaging technology, is able to
identify cancer invasion in the body and assess patient response to
chemotherapy. It is also useful in colorectal cancer diagnosis and treatment by
providing useful information that directly affects treatment options.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2191
Browse 27 Market Data Tables and
31 Figures spread through 180 Pages and in-depth TOC on "Molecular Imaging
Market, by Technology (Gamma Camera, SPECT, PET, Magnetic Resonance
Spectroscopy, Optical Imaging, and Molecular Ultrasound Imaging), by
Application (Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder,
Lung Disorder, Bone Disorder, and Others), by End User (Hospital, Diagnostic
Imaging Centers, and Others), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
Manufacturers are focused on
research and development to integrate advanced medical technologies for in
vitro diagnosis. For instance, in 2014, Philips Healthcare received the U.S.
FDA approval for spectral imaging system (IQon Spectral CT). The IQon Spectral
CT is a leading, new, high standard for medical imaging. As per the study conducted
by Radiological Society of North America, in 2013, Philips IQon Spectral CT
system exhibited enhanced diagnosis in up to 70% cases as compared to
conventional imaging methods. With rapid technological advancements, targeted
therapy, presymptomatic detection, and personalized medicine are possible in
future with the use multimodal molecular imaging. Moreover, researchers are
using molecular imaging to identify the strategies for developing new drugs and
to design clinical trials to test their effectiveness. Information provided by
molecular imaging technologies has the potential to accelerate the drug
development and approval process by making it less expensive and more
effective.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/molecular-imaging-market-2191
Key Takeaways of the Molecular
Imaging Market:
The global molecular imaging
market is expected to expand at a CAGR of 8.1% during the forecast period
(2018–2026), owing to increasing demand for early disease detection coupled
with rising prevalence of cancer and other chronic diseases.
Among technology, the SPECT
segment is expected to generate significant revenue in 2018, owing to advanced
radionuclide molecular imaging techniques that are able to evaluate biochemical
changes and levels of molecular targets within a living subject.
Major players operating in the
global molecular imaging market include Carestream Health, Fujifilm Holdings
Corporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG, Philips
Healthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical Systems
Corporation.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2191
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment